Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

<jats:p>Often regarded as “benign,”<jats:italic>Plasmodium vivax</jats:italic>infections lay in the shadows of the much more virulent<jats:italic>P. falciparum</jats:italic>infections. However, about 1.98 billion people are at risk of both parasites worldwide, stressing the need to understand the epidemiology of<jats:italic>Plasmodium vivax</jats:italic>, particularly under the scope of decreasing<jats:italic>P. falciparum</jats:italic>prevalence and ecological interactions between both species. Two epidemiological observations put the dynamics of both species into perspective: (1) ACT campaigns have had a greater impact on<jats:italic>P. falciparum</jats:italic>prevalence. (2) Complete clinical immunity is attained at younger ages for<jats:italic>P. vivax</jats:italic>, under similar infection rates. We systematically compared two mathematical models of transmission for both Plasmodium species. Simulations suggest that an ACT therapy combined with a hypnozoite killing drug would eliminate both species. However,<jats:italic>P. vivax</jats:italic>elimination is predicted to be unstable. Differences in age profiles of clinical malaria can be explained solely by<jats:italic>P. vivax</jats:italic>'s ability to relapse, which accelerates the acquisition of clinical immunity and serves as an immunity boosting mechanism.<jats:italic>P. vivax</jats:italic>transmission can subsist in areas of low mosquito abundance and is robust to drug administration initiatives due to relapse, making it an inconvenient and cumbersome, yet less lethal alternative to<jats:italic>P. falciparum</jats:italic>.</jats:p>

Original publication

DOI

10.1155/2012/921715

Type

Journal

Journal of Parasitology Research

Publisher

Hindawi Limited

Publication Date

2012

Volume

2012

Pages

1 - 8